Sun Pharma, Lupin, Dr Reddy's recall products in US market

Sun Pharma, Lupin, Dr Reddy's recall products in US market

Sun Pharma, Lupin, Dr Reddy's recall products in US market

Lupin Secures FDA Nod for Liraglutide and Glucagon Injectables - BioPatrika

Lupin Strengthens Diabetes Care Portfolio In a significant stride towards expanding its complex generics portfolio, Lupin Limited, a global pharmaceutical leader based in Mumbai, has received the U.S. Food and Drug Administration (USFDA) approval for two crucial injectable therapies—Liraglutide Injection and Glucagon for Injection. These approvals mark a strategic win for Lupin as it continues […] The post Lupin Secures FDA Nod for Liraglutide a…

Sun Pharma, Lupin, Dr. Reddy's Recall Products In US market

As per the latest Enforcement Report of US Food and Drug Administration, the Mumbai-headquartered Sun Pharmaceutical Industries is recalling 5,448 bottles of a generic medication in the US.

Sun Pharma, Lupin, Dr Reddy’s recall medicines in US over quality...

Last Updated on July 27, 2025 by Team THIP Mumbai, July 27 (IANS) Indian pharmaceutical companies Sun Pharma, Lupin, and Dr Reddy’s Laboratories are recalling some of their medicines from the US market due to manufacturing problems and product mix-ups, as per the US Food and Drug Administration (USFDA) latest enforcement report. Sun Pharmaceutical Industries, […] The post Sun Pharma, Lupin, Dr Reddy’s recall medicines in US over quality issues a…